Adagio Medical has submitted a premarket approval (PMA) application to the FDA for its vCLAS ventricular ablation system.

The Oura Ring creator’s plans to go public follow a $900m fundraise in October 2025 that put the company at an $11bn valuation.

Medtronic is set to acquire SPR Therapeutics for an upfront cash payment of nearly $650m, expanding care options for individuals with chronic pain.

OncoSil Medical has secured the Australian TGA approval for its OncoSil device, permitting its use in the treatment of LAPC alongside gemcitabine-based chemotherapy.

Boston Scientific has announced a $1.5bn investment to acquire a 34% equity stake in implants and procedural solutions developer MiRus.

The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways ...

Lawrence Tallon on priorities as MHRA CEO, the evolution of UK medical device regulation and the agency’s future leadership.

Cagent will use the funds to complete a pivotal trial of its Serranator SONIC IVL system and support commercial necessitates for the platform.

Endologix has acquired the Pounce mechanical thrombectomy system from Surmodics to expand its vascular intervention portfolio.

Lawrence Tallon, CEO of the MHRA, discusses the agency's initiatives to advance the UK's regulatory protocols for medical devices.

Embecta has completed its acquisition of UK medical device manufacturer Owen Mumford Holdings in a deal valued at up to £150m ($172.6m).

As per a 2019 deal, Artivion secured the rights to purchase Endospan upon the latter’s US approval of Nexus, a treatment for aortic arch syndrome.